ClearPoint Neuro (CLPT) Gains from Sales and Divestitures (2018 - 2026)

ClearPoint Neuro has disclosed Gains from Sales and Divestitures across 7 years of filings, most recently posting $748681.0 for Q1 2026.

• Gains from Sales and Divestitures for Q1 2026 came in at $748681.0, up 5660.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $748681.0 (up 5660.86% YoY), and the FY2025 annual result was $620493.0, up 129.24% from the prior year.
• Gains from Sales and Divestitures came in at $748681.0 for Q1 2026 at ClearPoint Neuro, up from $620493.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $748681.0 in Q1 2026 to a low of $12996.0 in Q1 2025.
• The 3-year median for Gains from Sales and Divestitures is $443945.5 (2024), against an average of $399915.8.
• Across the five-year window, Gains from Sales and Divestitures surged 129.24% in 2025 and surged 5660.86% in 2026, its largest moves.
• ClearPoint Neuro's Gains from Sales and Divestitures stood at $270673.0 in 2024, then soared by 129.24% to $620493.0 in 2025, then increased by 20.66% to $748681.0 in 2026.
• The last three Gains from Sales and Divestitures figures came in at $748681.0 (Q1 2026), $620493.0 (Q4 2025), and $617218.0 (Q3 2025), per Business Quant data.